The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm
Parthenolide (PTL or PAR) was first isolated from Magnolia grandiflora and identified as a small molecule cancer inhibitor. PTL has the chemical structure of C15H20O3 with characteristics of sesquiterpene lactones and exhibits the biological property of inhibiting DNA biosynthesis of cancer cells. I...
Main Authors: | Sipin Zhu, Ping Sun, Samuel Bennett, Oscar Charlesworth, Renxiang Tan, Xing Peng, Qiang Gu, Omar Kujan, Jiake Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1111218/full |
Similar Items
-
Parthenolide: suggested drug for COVID-19
by: M. Nemati, et al.
Published: (2020-11-01) -
The Molecular Structure and Role of Humanin in Neural and Skeletal Diseases, and in Tissue Regeneration
by: Sipin Zhu, et al.
Published: (2022-03-01) -
Parthenolide Induces Reactive Oxygen Species-Mediated Autophagic Cell Death in Human Osteosarcoma Cells
by: Chen Yang, et al.
Published: (2016-11-01) -
Trends in parthenolide research over the past two decades: A bibliometric analysis
by: Jiye Liu, et al.
Published: (2023-07-01) -
Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells
by: Song-Tian Che, et al.
Published: (2019-10-01)